A Lancet trial found that adults who continued tirzepatide after major weight loss maintained more of their weight loss than those switched to placebo.
New Research Confirms GLP-1 Medications Protect the Heart, Not Just Blood Sugar: cardiovascular outcome trial evidence, who benefits most, and how this drug.
Mounjaro: A New Weight Loss Medication for Adults with Type 2 Diabetes: how it works, who it’s used for, common side effects, and current NICE NG28 guidance.
Mounjaro: A New Weight Loss Medication for Adults with Type 2 Diabetes: how it works, who it’s used for, common side effects, and current NICE NG28 guidance.
